Hogan Lovells Advises Fresenius Kabi on Brazilian Asset Transfer
Deal News | Apr 11, 2025 | Hogan Lovells
Hogan Lovells, a major international law firm, is advising Fresenius Kabi, a global health care company, on the transfer of its production site in Anápolis and logistics operations in Goiânia, Brazil, to another company, EMS. This transaction is currently pending regulatory approval. By divesting these operations, Fresenius Kabi aims to streamline its production network as part of its broader global strategic objectives to enhance operational efficiency. Despite this divestiture, Fresenius Kabi maintains a strong presence in Brazil, with a diverse portfolio across Biopharma, Nutrition, Pharma, and MedTech sectors. The transaction underlines the company's commitment to delivering high-quality healthcare solutions in the region. Hogan Lovells has facilitated all legal aspects of the deal with a team of experts specializing in corporate M&A and life sciences regulatory sectors.
Sectors
- Healthcare
- Legal Services
Geography
- Brazil – The transaction involves Fresenius Kabi's operations in Anápolis and Goiânia, Brazil.
- Germany – Hogan Lovells' legal team advising Fresenius Kabi is based out of Frankfurt, Hamburg, and Munich, Germany.
Industry
- Healthcare – Fresenius Kabi operates in the healthcare industry, providing solutions in Biopharma, Nutrition, Pharma, and MedTech.
- Legal Services – Hogan Lovells is providing legal advisory services for the transaction.
Financials
- Not disclosed – The financial terms of the transaction have not been disclosed.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Fresenius Kabi | Selling Company | Company | A global healthcare company focusing on Biopharma, Nutrition, Pharma, and MedTech solutions. |
| EMS | Bidding Company | Company | Acquiring the Anápolis production site and Goiânia logistics operations from Fresenius Kabi. |
| Hogan Lovells | Legal Advisor | Company | An international law firm advising Fresenius Kabi on the transaction. |